Having obtained the first Marketing Authorization in 1989, PHARMGHREB has continued to evolve to reach after more than 30 years of experience, more than 120 Finish product affecting several therapeutic areas. PHARMAGHREB manufactures its own generic drugs, products under license from internationally renowned donors as well as subcontracted products. The laboratories have equipment equipped with cutting-edge technology enabling them to respond to the manufacture of the following 3 forms:
-Liquids: Solution, syrup, suspension
-Cream: gel, ointment, suppository
-Dry: tablets, capsules, sachet, powder
